David Ruggieri

1.2k total citations · 2 hit papers
10 papers, 754 citations indexed

About

David Ruggieri is a scholar working on Molecular Biology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David Ruggieri has authored 10 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David Ruggieri's work include Metabolomics and Mass Spectrometry Studies (2 papers), Ovarian function and disorders (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). David Ruggieri is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (2 papers), Ovarian function and disorders (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). David Ruggieri collaborates with scholars based in United States, France and Australia. David Ruggieri's co-authors include Katherine A. McGlynn, Mathieu Laversanne, Jessica L. Petrick, Freddie Bray, Ariana Znaor, Jacques Ferlay, Christian S. Álvarez, Andrea A. Florio, Patricia C. Valery and Judith S. Hochman and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and American Journal of Epidemiology.

In The Last Decade

David Ruggieri

8 papers receiving 751 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International trends in hepatocellular carcinoma incidence, 1978–2012

2019 392 citations Jessica L. Petrick, Andrea A. Florio et al. International Journal of Cancer profile →
Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012

2020 184 citations Andrea A. Florio, Jacques Ferlay et al. Cancer profile →

Peers

Countries citing papers authored by David Ruggieri

Since Specialization

Citations

This map shows the geographic impact of David Ruggieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ruggieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ruggieri more than expected).

Fields of papers citing papers by David Ruggieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ruggieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ruggieri. The network helps show where David Ruggieri may publish in the future.

Co-authorship network of co-authors of David Ruggieri

This figure shows the co-authorship network connecting the top 25 collaborators of David Ruggieri. A scholar is included among the top collaborators of David Ruggieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ruggieri. David Ruggieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Validation of TypeSeq2, a Next-Generation–Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica Laboratories 2025 ·The Journal of Infectious Diseases ·Mónica S. Sierra, Celia E. Coto, Carolina Porras, Rolando Herrero, (unknown), (unknown), (unknown), Carlos Montes, John Schussler, (unknown), Belynda Hicks, David Ruggieri, Bernal Cortés, Allan Hildesheim, Aimée R. Kreimer, Nicolas Wentzensen, Casey Dagnall, Danping Liu	0
2	metLinkR: Facilitating Metaanalysis of Human Metabolomics Data through Automated Linking of Metabolite Identifiers 2025 ·Journal of Proteome Research ·Andrew Patt, (unknown), F. Eun-Hyung Lee, (unknown), Eoin Fahy, Victoria L. Stevens, David Ruggieri, Steven C. Moore, Ewy A. Mathé	0
3	Assessment of prenatal depression among U.S. pregnant women without access to paid sick leave and regular place of care: National Health Interview Survey of U.S.-born and non-U.S.-born 2023 ·Preventive Medicine Reports ·(unknown), David Adzrago, (unknown), Emmanuel Odame, (unknown), (unknown), David Ruggieri, Lisa Kahle, Faustine Williams	4
4	COMETS Analytics: An Online Tool for Analyzing and Meta-Analyzing Metabolomics Data in Large Research Consortia 2021 ·American Journal of Epidemiology ·Marinella Temprosa, Steven C. Moore, Krista A. Zanetti, Nathan M. Appel, David Ruggieri, (unknown), (unknown), Rachel S. Kelly, Jessica Lasky‐Su, Erikka Loftfield, Kathleen M. McClain, Brian Park, Laura Trijsburg, Oana A. Zeleznik, Ewy A. Mathé	8
5	Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012 breakdown → 2020 ·Cancer ·Andrea A. Florio, Jacques Ferlay, Ariana Znaor, David Ruggieri, Christian S. Álvarez, Mathieu Laversanne, Freddie Bray, Katherine A. McGlynn, Jessica L. Petrick	184
6	International trends in hepatocellular carcinoma incidence, 1978–2012 breakdown → 2019 ·International Journal of Cancer ·Jessica L. Petrick, Andrea A. Florio, Ariana Znaor, David Ruggieri, Mathieu Laversanne, Christian S. Álvarez, Jacques Ferlay, Patricia C. Valery, Freddie Bray, Katherine A. McGlynn	392
7	Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women 2016 ·JNCI Journal of the National Cancer Institute ·Steven C. Moore, Charles E. Matthews, Xiao Ou Shu, Kai Yu, Mitchell H. Gail, Xia Xu, Bu-Tian Ji, Wong‐Ho Chow, Qiuyin Cai, Honglan Li, Gong Yang, David Ruggieri, (unknown), Nathaniel Rothman, Robert N. Hoover, Yu-Tang Gao, Wei Zheng, Regina G. Ziegler	72
8	Effects of fertility drugs on cancers other than breast and gynecologic malignancies 2015 ·Fertility and Sterility ·Louise A. Brinton, Kamran S. Moghissi, Bert Scoccia, Emmet J. Lamb, Britton Trabert, Shelley Niwa, David Ruggieri, Carolyn Westhoff	23
9	Long-term Relationship of Ovulation-Stimulating Drugs to Breast Cancer Risk 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Louise A. Brinton, Bert Scoccia, Kamran S. Moghissi, Carolyn Westhoff, Shelley Niwa, David Ruggieri, Britton Trabert, Emmet J. Lamb	30
10	The distribution of atherosclerotic lesions in the coronary arterial tree: Relation to cardiac risk factors 1988 ·American Heart Journal ·Judith S. Hochman, William J. Phillips, David Ruggieri, Stephen F. Ryan	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact